Achillion Gets Fast Track Designation for ACH-3102 to Treat Chronic Hepatitis C

Achillion Pharmaceuticals announced the receipt of a fast track designation from the Food and Drug Administration for ACH-3102 as part of an interferon-free regimen for the treatment of chronic hepatitis C.
RTTnews